1. Home
  2. KSPI vs EXAS Comparison

KSPI vs EXAS Comparison

Compare KSPI & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

KSPI

Joint Stock Company Kaspi.kz

HOLD

Current Price

$79.31

Market Cap

13.6B

Sector

N/A

ML Signal

HOLD

Logo Exact Sciences Corporation

EXAS

Exact Sciences Corporation

HOLD

Current Price

$101.51

Market Cap

11.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KSPI
EXAS
Founded
2008
1995
Country
Kazakhstan
United States
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.6B
11.0B
IPO Year
2024
N/A

Fundamental Metrics

Financial Performance
Metric
KSPI
EXAS
Price
$79.31
$101.51
Analyst Decision
Buy
Buy
Analyst Count
2
20
Target Price
$113.00
$77.94
AVG Volume (30 Days)
542.1K
11.0M
Earning Date
11-10-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
13.36
N/A
EPS
10.48
N/A
Revenue
$6,665,289,776.00
$3,082,033,000.00
Revenue This Year
$39.99
$19.40
Revenue Next Year
$19.87
$13.51
P/E Ratio
$7.52
N/A
Revenue Growth
54.22
14.47
52 Week Low
$70.61
$38.81
52 Week High
$111.45
$101.95

Technical Indicators

Market Signals
Indicator
KSPI
EXAS
Relative Strength Index (RSI) 62.39 87.70
Support Level $74.98 $101.30
Resistance Level $77.77 $101.93
Average True Range (ATR) 2.12 0.34
MACD 0.42 -1.29
Stochastic Oscillator 80.11 53.50

Price Performance

Historical Comparison
KSPI
EXAS

About KSPI Joint Stock Company Kaspi.kz

Kaspi.kz JSC is the payment, marketplace, and Fintech ecosystem in Kazakhstan. The firm provides interconnected technologically seamless products and services that help people to pay, shop and manage their finances. Its operating segment includes the Payments Platform that connects its customers, which consist of both consumers and merchants, to facilitate cashless, digital transactions, the Marketplace Platform that connects merchants and consumers enabling merchants to increase their sales and consumers to buy a broad selection of products and services offered by a variety of merchants, and Fintech Platform that enables customers to manage their personal finances online and access consumer finance and deposit products through the Kaspi.kz Super App.

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

Share on Social Networks: